Nature, 2023 Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19 Sparks R., Lau W., Liu C. et al. Olink Target 96Infectious DiseasesPathophysiologySerum | | | | |
International Journal of Molecular Sciences, 2023 Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer’s Disease Aetiopathogenesis in Men García-González P., de Rojas I., Moreno-Grau S. et al. Olink Target 96NeurologyPathophysiologyPlasmaCSF | | | | |
European Journal of Heart Failure, 2023 Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome van der Hoef C., Boorsma E., Emmens J. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPatient StratificationPlasma | | | | |
PLOS Neglected Tropical Diseases, 2023 Longitudinal proteomic profiling of the inflammatory response in dengue patients Garishah F., Boahen C., Vadaq N. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma | | | | |
Nature Biotechnology, 2023 Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models Allesøe R., Lundgaard A., Hernández Medina R. et al. Olink Target 96Metabolic DiseasesData SciencePlasma | | | | |
Alzheimer's & Dementia, 2022 Characterization of the contactin 5 protein and its risk‐associated polymorphic variant throughout the Alzheimer's disease spectrum Dauar M., Labonté A., Picard C. et al. Olink Target 96NeurologyPathophysiologyCSF | | | | |
The Journal of Dermatology, 2022 Unique protein signatures evolve during the course of a delayed‐type hypersensitivity reaction in human skin Han J., Stratman S., Young J. et al. Olink Target 96Dermatological DiseasesPathophysiologyTissue Lysate | | | | |
The Journal of Infectious Diseases, 2022 Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV Reilly C., Borges ?., Baker J. et al. Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma | | | | |
PLOS ONE, 2022 Effect of repeated bolus and continuous glucose infusion on a panel of circulating biomarkers in healthy volunteers Feldbauer R., Heinzl M., Klammer C. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Clinical Proteomics, 2022 Novel plasma protein biomarkers from critically ill sepsis patients Van Nynatten L., Slessarev M., Martin C. et al. Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma | | | | |
Biomaterials, 2022 Immuno-engineered mRNA combined with cell adhesive niche for synergistic modulation of the MSC secretome Drzeniek N., Kahwaji N., Schlickeiser S. et al. Olink Target 96Technical StudiesTechnical EvaluationCell Culture Supernatant | | | | |
Scientific Reports, 2022 Proteomic profiling of a patient with cutaneous melanoma metastasis regression following topical contact sensitizer diphencyprone and immune checkpoint inhibitor treatment Han J., Agarwal A., Young J. et al. Olink Target 96OncologyImmunotherapyPathophysiologySerumTissue Lysate | | | | |
Science Advances, 2022 Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice Liu J., Lane S., Lall R. et al. Olink Target 96OncologyCVDPathophysiologyBlood | | | | |
Vaccines, 2022 Reinfection with SARS-CoV-2 and Waning Humoral Immunity: A Case Report Goldman J., Wang K., Röltgen K. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Respiratory Research, 2022 Exhaled phospholipid transfer protein and hepatocyte growth factor receptor in lung adenocarcinoma Andreasson J., Bodén E., Fakhro M. et al. Olink Target 96OncologyPatient StratificationExhaled Breath Particles (EBP) | | | | |
Biomedicine & Pharmacotherapy, 2022 Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC study Zapater A., Gracia-Lavedan E., Torres G. et al. Olink Target 96Respiratory DiseasesCVDPathophysiologyPatient StratificationPlasma | | | | |
Journal of Cellular and Molecular Medicine, 2022 COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management Iosef C., Martin C., Slessarev M. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Heliyon, 2022 Increased mitochondrial proton leak and glycolysis in peripheral blood mononuclear cells in type-1-diabetes Lopes de Melo J., Laursen J., Søndergaard-Heinrich N. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Arthritis & Rheumatology, 2022 Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides Brink M., Berglin E., Mohammad A. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasmaSerum | | | | |
BMC Medicine, 2022 Systematic analysis of relationships between plasma branched-chain amino acid concentrations and cardiometabolic parameters: an association and Mendelian randomization study Doestzada M., Zhernakova D., C. L. van den Munckhof I. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |